Last edition
News about
Glenmark Gets ANDA Approval for Topiramate Capsules
Glenmark Pharmaceuticals Ltd. has been granted final approval by the United States Food and Drug Administration (US FDA) for Topiramate Capsules USP, 15 mg and 25 mg.
Mankind Pharma Signs License Deal with Takeda to Commercialise Acidity Drug in India
Mankind Pharma has signed a non-exclusive patent licence agreement with Takeda Pharmaceuticals for commercialising acidity drug Vonoprazan in the Indian market.
ForDoz Secures US FDA Approval for Doxorubicin Hydrochloride Liposome Injection
Lupin has announced that its alliance partner, ForDoz Pharma Corp. has received approval from US FDA for its Abbreviated New Drug Application for Doxorubicin Hydrochloride Liposome Injection, Single-Dose Vials, to market a generic equivalent of Doxil Liposom.
MOLLI Surgical to Adopt MOLLI Surgical's Breast Cancer Technology
MOLLI Surgical's wire-free and radiation-free technology for localizing lesions for breast cancer surgery improves the patient experience and has earned praise from surgeons for its accuracy and ease of use.
Wearable Medical Devices Market Size Set to Grow by USD 26.55 Bn from 2024-2028
The market is estimated to grow at a CAGR of almost 23.31% during the forecast period. Increasing prevalence of chronic diseases globally is driving market growth, with a trend towards emergence of innovative wearable medical devices.
Nipro Establishes New Medical Device Manufacturing Facility in North Carolina
Nipro Medical Corporation has announced expansion in the United States with the establishment of its first North American manufacturing facility in Greenville, North Carolina.
Avallano Unveils AI-Based Clinical Research Protocol Assistant ProtocolCopilot
Avallano has introduced ProtocolCopilot, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols.
Lupin Gets Tentative Approval from US FDA for RLD Sutab
Lupin has secured tentative approval from US FDA for its Abbreviated New Drug Application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g, to market a generic equivalent of Sutab Tablets, 1.479 g/0.225 g/0.188 g, of Braintree Laboratories Inc.
Mabwell Gets NMPA Approval for Clinical Trial of Nectin-4 Targeting ADC in TNBC
Mabwell has announced that its novel Nectin-4 targeting ADC has been approved by the NMPA to enter Phase II clinical trial as monotherapy or in combination with a PD-1 inhibitor for the treatment of triple-negative breast cancer (TNBC).
Modicus Prime Secures USD 3.5 Million in Series Seed Funding
Modicus Prime has received USD 3.5 million in series seed funding led by Silverton Partners, with additional backing from Alumni Ventures and other leading venture firms.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy